BioMarin Pharmaceutical
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
22.0016.7912.429.48
Price/Sales ratio
3.393.052.762.50
Earnings per Share (EPS)
$2.59$3.39$4.58$6.00

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-98.26-97.58-21.81-132.88-195.26-634.7518.56-252.10135.44108.03128.57-195.26
Price/Sales ratio
17.5218.8312.3111.8410.118.888.528.759.147.488.688.88
Price/Book Value ratio
8.616.984.975.535.074.843.863.784.163.653.954.84
Price/Cash Flow ratio
-179.00-75.62-60.35-1.77K746.07313.65185.7253.04108.99113.72103.47313.65
Price/Free Cash Flow ratio
-68.42-37.30-36.54-74.78-121.18-131.46-303.9987.17432.19350.66410.28-121.18
Price/Earnings Growth ratio
3.49-5.98-0.081.615.689.00-0.002.34-0.426.310.419.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
82.72%82.91%81.23%81.59%78.85%78.90%71.82%74.51%76.92%76.14%76.92%78.90%
Operating Profit Margin
-12.36%-12.43%-71.93%-1.11%-8.28%-7.36%-5.17%-3.25%2.74%8.03%1.98%-8.28%
Pretax Profit Margin
-16.62%-17.38%-74.40%-2.73%-9.56%-5.56%-2.27%-4.08%7.13%7.79%7.13%-9.56%
Net Profit Margin
-17.83%-19.30%-56.42%-8.90%-5.17%-1.39%45.90%-3.47%6.75%6.92%6.75%-5.17%
Effective Tax Rate
-7.28%-11.03%24.16%-226.24%45.89%74.84%2129.91%14.95%5.35%11.09%5.35%74.84%
Return on Assets
-5.37%-4.60%-15.66%-2.52%-1.74%-0.50%14.60%-1.06%2.22%2.45%2.22%-1.74%
Return On Equity
-8.76%-7.15%-22.78%-4.16%-2.60%-0.76%20.79%-1.50%3.07%3.38%3.13%-2.60%
Return on Capital Employed
-4.11%-3.37%-22.41%-0.38%-3.16%-3.33%-1.79%-1.09%0.99%3.43%0.72%-3.16%
Liquidity Ratios
Current Ratio
6.042.443.232.703.922.084.75N/AN/AN/A4.673.92
Quick Ratio
5.201.832.422.122.911.353.332.773.151.572.972.91
Cash ratio
3.710.890.920.730.940.461.311.081.230.641.230.94
Days of Sales Outstanding
70.2167.6570.3572.6283.8680.8387.9673.8180.3395.6080.3380.83
Days of Inventory outstanding
561.01652.36618.36718.22614.62690.74486.33602.49674.71700.30674.71614.62
Operating Cycle
631.23720.02688.71790.85698.48771.58574.29676.31755.05795.91694.52771.58
Days of Payables Outstanding
9.53430.51333.19251.52240.37244.69133.27149.72174.50199.56174.50244.69
Cash Conversion Cycle
621.69289.50355.52539.32458.11526.89441.01526.59580.54596.3572.19526.89
Debt Ratios
Debt Ratio
0.260.170.160.250.180.180.180.170.160.150.270.18
Debt Equity Ratio
0.430.270.240.410.270.270.260.250.230.210.380.27
Long-term Debt to Capitalization
0.300.210.190.220.210.130.200.200.190.100.190.13
Total Debt to Capitalization
0.300.210.190.290.210.210.200.200.190.180.190.21
Interest Coverage Ratio
-4.81-8.05-5.65-3.58-4.33-5.85-3.13N/AN/AN/A2.70-4.33
Cash Flow to Debt Ratio
-0.11-0.33-0.33-0.000.020.050.070.280.160.140.160.02
Company Equity Multiplier
1.621.551.451.641.491.501.421.401.381.381.381.50
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.09-0.24-0.20-0.000.010.020.040.160.080.060.080.01
Free Cash Flow / Operating Cash Flow Ratio
2.612.021.6523.74-6.15-2.38-0.610.600.250.320.25-6.15
Cash Flow Coverage Ratio
-0.11-0.33-0.33-0.000.020.050.070.280.160.140.160.02
Short Term Coverage Ratio
N/AN/A-10.13-0.02N/A0.13N/AN/AN/A0.3216.950.13
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A